JP2017505621A5 - - Google Patents

Download PDF

Info

Publication number
JP2017505621A5
JP2017505621A5 JP2016549152A JP2016549152A JP2017505621A5 JP 2017505621 A5 JP2017505621 A5 JP 2017505621A5 JP 2016549152 A JP2016549152 A JP 2016549152A JP 2016549152 A JP2016549152 A JP 2016549152A JP 2017505621 A5 JP2017505621 A5 JP 2017505621A5
Authority
JP
Japan
Prior art keywords
tcr
bait
polypeptide chain
nucleic acid
chain
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2016549152A
Other languages
English (en)
Japanese (ja)
Other versions
JP2017505621A (ja
JP6580579B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/CA2015/000049 external-priority patent/WO2015113140A1/en
Publication of JP2017505621A publication Critical patent/JP2017505621A/ja
Publication of JP2017505621A5 publication Critical patent/JP2017505621A5/ja
Application granted granted Critical
Publication of JP6580579B2 publication Critical patent/JP6580579B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2016549152A 2014-01-29 2015-01-28 Ｔ細胞受容体を発現する細胞を生産する方法および組成物 Active JP6580579B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201461933048P 2014-01-29 2014-01-29
US61/933,048 2014-01-29
PCT/CA2015/000049 WO2015113140A1 (en) 2014-01-29 2015-01-28 Methods and compositions for producing a cell expressing a t cell receptor

Publications (3)

Publication Number Publication Date
JP2017505621A JP2017505621A (ja) 2017-02-23
JP2017505621A5 true JP2017505621A5 (enExample) 2018-03-08
JP6580579B2 JP6580579B2 (ja) 2019-09-25

Family

ID=53756056

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2016549152A Active JP6580579B2 (ja) 2014-01-29 2015-01-28 Ｔ細胞受容体を発現する細胞を生産する方法および組成物

Country Status (5)

Country Link
US (1) US10654907B2 (enExample)
EP (1) EP3099708B1 (enExample)
JP (1) JP6580579B2 (enExample)
CA (1) CA2934729C (enExample)
WO (1) WO2015113140A1 (enExample)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2998270A1 (en) * 2015-10-01 2017-04-06 Ospedale San Raffaele S.R.L. Tcr and uses thereof
JP7114477B2 (ja) 2015-12-16 2022-08-08 グリットストーン バイオ インコーポレイテッド 新生抗原の特定、製造、および使用
US11214789B2 (en) 2016-05-03 2022-01-04 Flodesign Sonics, Inc. Concentration and washing of particles with acoustics
JP7054397B2 (ja) * 2016-06-27 2022-04-13 ジュノー セラピューティクス インコーポレイテッド Ｍｈｃ－ｅ拘束性エピトープ、結合分子ならびに関連する方法および使用
CN109804246B (zh) * 2016-08-01 2022-05-17 健康研究公司 用于快速克隆t细胞受体的组合物和方法
US10822662B2 (en) * 2017-03-06 2020-11-03 Karkinos Precision Oncology LLC Diagnostic methods for identifying T-cell lymphoma and leukemia by high-throughput TCR-β sequencing
CN111465989B (zh) 2017-10-10 2024-06-25 磨石生物公司 使用热点进行的新抗原鉴别
AU2018373154B2 (en) 2017-11-22 2025-08-07 Seattle Project Corp. Reducing junction epitope presentation for neoantigens
US20220062341A1 (en) * 2018-12-26 2022-03-03 Kirin Holdings Kabushiki Kaisha Modified tcr and production method therefor
AU2020218446B2 (en) 2019-02-04 2023-05-25 National University Corporation Ehime University "CAR LIBRARY AND scFv MANUFACTURING METHOD
GB202211194D0 (en) * 2022-08-01 2022-09-14 Univ College Cardiff Consultants Ltd Novel TCRs
WO2026019786A1 (en) * 2024-07-16 2026-01-22 Board Of Regents, The University Of Texas System Peptides and engineered t cell receptors targeting brachyury antigen and methods of use

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1795599A1 (en) * 2005-12-09 2007-06-13 Schuler, Gerold, Prof. Dr. Methods for generating antigen-specific effector T cells
WO2008042814A2 (en) 2006-09-29 2008-04-10 California Institute Of Technology Mart-1 t cell receptors
EP3031916B1 (en) * 2007-06-11 2017-06-07 Takara Bio Inc. Method for expression of specific gene
CN102272153B (zh) * 2008-11-24 2015-04-15 德国慕尼黑亥姆霍兹研究中心健康和环境有限公司 高亲和力t细胞受体及其应用
WO2010089412A1 (en) * 2009-02-09 2010-08-12 Helmholtz Zentrum Muenchen Deutsches Forschungszentrum Fuer Gesundheit Und Umwelt (Gmbh) Repertoire of allo-restricted peptide-specific t cell receptor sequences and use thereof
US9345748B2 (en) 2010-09-21 2016-05-24 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Anti-SSX-2 T cell receptors and related materials and methods of use
WO2012104843A1 (en) * 2011-02-06 2012-08-09 Yeda Research And Development Co.Ltd. At The Weizmann Institute Of Science Affinity maturated t cell receptors and use thereof
WO2012154858A1 (en) * 2011-05-09 2012-11-15 Whitehead Institute For Biomedical Research Chaperone interaction assays and uses thereof
ES2835200T3 (es) 2012-05-22 2021-06-22 Us Health Uso médico de células que comprenden receptores de células T anti-NY-ESO-1

Similar Documents

Publication Publication Date Title
JP7439002B2 (ja) ヒト化抗ｃｄ１９キメラ抗原受容体を使用するがんの処置
ES2963718T3 (es) Capacidad presentadora de antígenos de células CAR-T potenciada mediante introducción conjunta de moléculas co-estimuladoras
JP2021118723A (ja) 免疫療法のためのマクロファージの遺伝子組換え
JP2018183175A (ja) Ｗｔ−１に特異的なｔ細胞免疫治療
KR20230152035A (ko) 표적 단백질 분해 시스템 및 이의 응용
TW201930591A (zh) 用於與嵌合抗原受體療法併用之免疫增強rna
TW201922774A (zh) 標靶bcma嵌合抗原受體、標靶cd19嵌合抗原受體及組合療法
JP7447014B2 (ja) インターロイキン２３受容体に特異的なキメラ抗原受容体
TW201827460A (zh) 改善配對的ｔ細胞受體
WO2018026819A2 (en) Treatment of cancer using a chimeric antigen receptor in combination with an inhibitor of a pro-m2 macrophage molecule
CN110139873A (zh) Hpv特异性结合分子
CN111448215A (zh) 抗-hla-a2抗体及其使用方法
KR20190016966A (ko) 길항성 항-종양 괴사 인자 수용체 슈퍼패밀리 항체
CN107708710A (zh) Smart CAR装置,DE CAR多肽,Side CAR及其使用
US20230044451A1 (en) Methods and compositions for the delivery of modified lymphocytes and/or retroviral particles
CN115135674A (zh) 树突细胞激活性嵌合抗原受体和其用途
CA3090249A1 (en) Combination therapy using a chimeric antigen receptor
EP4529466A1 (en) Binding proteins and engineered cells specific for neoantigens and uses thereof
JP2023500318A (ja) 細胞選択および／または細胞刺激デバイスならびに使用方法
CN120917046A (zh) 新型cd19结合剂、包含所述cd19结合剂的car-t构建体及其使用方法
US20210340524A1 (en) Methods for identifying chimeric antigen receptor-targeting ligands and uses thereof
WO2021074313A1 (en) Chimeric antigen receptor specific for interleukin-23 receptor
WO2023010068A2 (en) Multiprotein-engineered cells secreting a multispecific antibody
CN117279945A (zh) 嵌合细胞因子受体及其在细胞疗法中的用途
WO2022232797A2 (en) Virus-specific immune cells expressing chimeric antigen receptors